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Abstract
Background: During transitions from hospital to home, up to half of all patients experience medication-related
problems, such as adverse drug events. To reduce these problems, knowledge of patient experiences with medication
use during this transition is needed. This study aims to identify the perspectives of patients on barriers and facilitators
with medication use, during the transition from hospital to home.
Methods: A qualitative study was conducted in 2017 among patients discharged from two hospitals using a semi-
structured interview guide. Patients were asked to identify all barriers they experienced with medication use during
transitions from hospital to home, and facilitators needed to overcome those barriers. Data were analyzed following
thematic content analysis and visualized using an “Ishikawa” diagram.
Results: In total, three focus groups were conducted with 19 patients (mean age: 70.8 (SD 9.3) years, 63% female).
Three barriers were identified; lack of personalized care in the care continuum, insufficient information transfer (e.g.
regarding changes in pharmacotherapy), and problems in care organization (e.g. medication substitution). Facilitators
to overcome these barriers included a personal medication-counselor in the care continuum to guide patients with
medication use and overcome communication barriers, and post-discharge follow-up care (e.g. home visits from
healthcare providers).
Conclusions: During transitions from hospital to home patients experience individual-, healthcare provider- and
organization level barriers. Future research should focus on personal-medication counselors in the care continuum and
post-discharge follow-up care as it may overcome communication, emotional, information and organization barriers
with medication use.
Keywords: Continuity of patient care, Medication errors, Focus groups, Qualitative research
Background
Research shows that the transition from hospital to
home presents a critical period for patient safety as it
can result in medication-related problems (MRPs)
post-discharge [1–3]. MRPs are defined as events or cir-
cumstances related to a patient’s medication therapy,
which can actually or potentially interfere with desired
health outcomes [4–6]. The prevalence of MRPs
post-discharge varies from 14 to 49% [7]. A recent study
showed that a median of 20% of hospital readmissions
are due to MRPs, of which 69% were regarded as pre-
ventable [8].
There are 4 key problems causing these MRPs in the tran-
sition from hospital to home. First, during hospitalization,
the hospital staff are responsible for daily management
and the intake of patient medication, while patients are
expected to self-manage their medication regimen after
discharge, often with limited guidance [9]. Second, if
instructions on medication changes are provided, this
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usually takes place at the time of discharge. However, at
discharge, patients are often distracted, overloaded with
information and eager to leave for home, therefore pay-
ing less attention to medication instructions [9]. Third,
oral and written instructions are not always adjusted to
patients’ literacy levels or informational needs [10, 11].
Consequently, most patients have difficulties implement-
ing the changed regimen in their daily lives [12–14].
Lastly, patients’ healthcare providers in primary care are
insufficiently informed regarding the reasons for medica-
tion changes and therefore have difficulties monitoring
patients’ entire medication regimens [14–16].
A powerful strategy for improving healthcare is the
introduction of patient-centered care, because it addresses
barriers by responding to patient-specific needs, prefer-
ences and values [17–19]. To design effective interven-
tions to reduce MRPs in the transition from hospital to
home, healthcare providers and organizations need to
understand patients’ perspectives and respond more fully
to their needs. This requires an understanding of barriers
that patients experience that could result in MRPs but also
of facilitators that could reduce MRPs. Until now, several
studies have identified patient barriers and facilitators at
transitions of care but focused on the hospital discharge
process in general rather than the transition from hospital
to home [20, 21] or observed post-discharge problems
throughout observations from healthcare providers [22].
Few studies have explored patient perspectives, specifically
focusing on medication. However, studies that did focus
on medication were limited as they studied only a specific
topic regarding barriers to medication use (e.g. communi-
cation failures) [23], focused primarily on barriers [24],
asked patients to reflect upon pre-defined barriers [25] or
studied the discharge moment itself rather than the transi-
tion from hospital to home [26]. Two studies identified
patients’ perceived barriers and facilitators with medica-
tion use by using a survey, so were therefore lacking a
deeper exploration of the issues [27, 28]. There is still
need for an exploration of those factors which patients
perceive as barriers and facilitators for the continuity of
medication use following hospital discharge. The aim of
this study therefore is to identify patients’ perspectives on
barriers and facilitators with medication use during the
transition from hospital to home.
Methods
This qualitative study is reported following the Consolidated
criteria for reporting qualitative research (COREQ) [29].
Study design and setting
A qualitative study was conducted in March 2017 with
patients from two Dutch hospitals (OLVG and BovenIJ)
using focus groups. The study was approved by the local
ethics committee “Adviescommissie Wetenschappelijk
Onderzoek-Medisch-Ethische Commissie” (ACWO-MEC)
OLVG hospital (ID WO: 15.067) and the Board of Direc-
tors BovenIJ hospital (ID WO: 5EMeh545).
Focus groups were chosen because this enables an
in-depth discussion among patients about their perspec-
tives of barriers and facilitators with medication use during
the transition from hospital to home. This qualitative study
was part of a previously conducted pharmacy-led transi-
tional care multicenter study in the Netherlands, which
took place in the OLVG and BovenIJ hospitals and 50 com-
munity pharmacies [30]. The intervention of this study con-
sisted of medication reconciliation during hospitalization,
including ‘teach-back’ at hospital discharge to check
whether medication changes had been clearly explained to
patients. Also, primary healthcare providers received an
overview listing reasons for in-hospital medication changes
and the community pharmacist visited the patient at home
within 5 days post-discharge.
Participants
This study focused on patients discharged from the de-
partments of internal medicine, cardiology, pulmonology
or neurology. Patients who received the intervention
from the pharmacy-led transitional care multicenter
study (n = 197, see Table 1 for all inclusion and exclusion
criteria) were eligible for participation in the focus
groups. Patients included in the first phase of the inter-
vention (n = 50) were excluded to limit recall-bias. The
participants were all prone to post-discharge MRPs as
they had to fulfil inclusion criteria which are associated
with the occurrence of MRPs [2, 3]. By selecting this
high-risk population, we expect to gain more insight into
barriers and facilitators, as patients are more likely to ex-
perience challenges during transitions of care and know
better what is needed to overcome these problems. Fur-
thermore, the intervention group was specifically chosen
because previous research showed that patient have diffi-
culties to address their needs when they do not know
how care can be organized [10]. Of the 147 eligible
patients, 125 (85.0%) were contacted by phone for par-
ticipation. The remaining patients were either deceased
(n = 6) or had withdrawn from the multicenter study
(n = 16). Contacted patients received oral study infor-
mation and 37 patients were interested in participating. Of
these, 24 patients randomly received a confirmation letter
by post. Prior to every focus group, written informed con-
sent was obtained from each participant, ensuring anonym-
ity and confidentiality of the information obtained.
Interview guide
A semi-structured interview guide was derived from dis-
cussion with a multi-disciplinary panel of clinicians, pa-
tient representatives and researchers, and consisted of 2
questions about (1) patients’ experiences on barriers
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with medication use during transitions from hospital to
home and (2) patients’ suggested facilitators on how to
overcome those barriers. Patients could stress any barriers
they had experienced during any transition from hospital
to home or reflect on those barriers that were experienced
by others, e.g. relatives or friends. The interview guide
was based on previous research of researchers who
have over 10 years’ experience with transitional care
and medication-related problems due to transitions in
care. This included interviews with patients on their in-
formational needs before and after discharge and sur-
veys to assess MRPs [10, 26].
Data collection
A trained focus group moderator who was not involved
in the pharmacy-led transitional care multicenter study
moderated the focus groups using the interview guide. A
list with examples of barriers and facilitators with medi-
cation use during transitions from hospital to home was
developed which the moderator could use in case partic-
ipants needed help (Additional file 1). Also, the first re-
searcher (XX) assisted the moderator if necessary, and
observed and made field notes during each focus group.
All focus groups were held in a hospital meeting room
and lasted from 1.5 to 2 h. After participation, patients
were rewarded with a 25 euro gift voucher. Focus groups
were audio recorded and transcribed verbatim. To en-
sure correct interpretation, member checking was done
for all the focus groups.
Data analysis
Transcripts were systematically analyzed using a thematic-
content approach in the software program MAXQDA ver-
sion 12. This comprised the initial generation of codes,
which were subsequently compared and grouped into
themes, followed by a thorough review of the themes.
First, two researchers (XX and YY) independently ana-
lyzed, compared and discussed the coding of the first tran-
script until consensus was achieved. Hereafter, the first
researcher (XX) coded the other transcripts, which was
completely reviewed by the second researcher (YY). Also,
any differences were discussed here. Both researchers
placed the codes into categories and subsequently into
sub- and main themes. Finally, the themes were thor-
oughly discussed in research group meetings until a con-
sensus was reached. Once the final themes were
identified, “Ishikawa” diagrams (i.e. fishbone diagrams)
were created to illustrate the identified barriers and facili-
tators [31]. This fishbone diagram is a structured tool to
understand contributing factors that lead to an effect or
problem. Representative quotes were selected for each
theme.
Results
In total, 3 focus groups were conducted with 19 patients
(3 cancelled due to health issues and 2 did not show up),
which lasted between 92 and 124 min. The demographic
characteristics of the participants (Additional file 2)
show similarities to the characteristics of the complete
intervention group population (Table 2).
During the focus groups, the example list of barriers
and facilitators (Additional file 1) was not used by the
moderator because there was a lot of discussion among
participants, as they reacted on each others experiences,
especially when they had to think of facilitators. In total,
3 main themes of barriers and 2 main themes of facilita-
tors were identified.
Barriers with medication use during the transition from
hospital to home
The identified themes and their subthemes are presented in
Fig. 1. In total, 3 main themes of barriers were identified:
(I) Lack of personalized care, categorized into 3
subthemes: (a) pre-discharge information on
medication use, management and side effects, (b)
emotional support from healthcare providers, and
(c) post-discharge follow-up.
(II) Insufficient information transfer, categorized into 2
subthemes: (a) communication between healthcare
providers and (b) medication overview.
(III)Problems in the organization of healthcare,
categorized into 2 subthemes: (a) organization of
the discharge process and (b) substitution of
medication.
Theme Ι – lack of personalized care
Pre-discharge information on medication use, management
and side effects
Patients indicate that discharge instructions on how to
use and manage medication at home are often not tai-
lored to their personal condition or needs, which can
Table 1 Patient inclusion and exclusion criteria [30]
Inclusion criteria Exclusion criteria
˗ Discharge from department: internal medicine, cardiology,
pulmonology or neurology
˗ ≥24 h hospital admission
˗ Use of ≥3 chronic prescription medications at discharge
˗ ≥1 change in medication regimen (intended for chronic use)
conducted during hospitalization
˗ Discharge to another institution, e.g. rehabilitation center or nursing home
˗ Patients who could not be counselled, as stated by hospital physicians or
nurses, due to physical/mental constraints, language restrictions or terminal
illness
˗ Patients included in the first phase of the intervention
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Table 2 Demographic characteristics of focus groups and total intervention group patients
Group 1 (n = 7) Group 2 (n = 7) Group 3 (n = 5) Overall (n = 19)
Age (years)
Mean ± SD 69.0 [9.3] 76.3 [5.3] 65.6 [11.3] 70.8 [9.3]
Gender
Male [n, (%)] 4 (57.1) 5 (71.4) 3 (60.0) 12 (63.2)
Number of medications at discharge
Mean ± SD 9.9 [3.0] 8.4 [3.7] 10.8 [2.3] 9.6 [3.1]
Number of in-hospital medication changes per patient
Mean ± SD 2.9 [1.3] 3.6 [2.0] 4.2 [2.6] 3.5 [1.9]
Help with medication use at home (e.g. homecare) [n, (%)] 1 (14.3) 2 (28.6) 0 (0) 3 (15.8)
Living situation [n, (%)]
Living alone 2 (28.6) 3 (42.9) 1 (20.0) 6 (31.6)
Living together 5 (71.4) 4 (57.1) 4 (80.0) 13 (68.4)
Hospital [n, (%)]
BovenIJ 6 (85.7) 1 (20.0) 7 (36.8)
OLVG 1 (14.3) 7 (100.0) 4 (80.0) 12 (63.2)
Admission type [n, (%)]
Unplanned 5 (71.4) 7 (100.0) 5 (100.0) 17 (89.5)
Planned 2 (28.6) 2 (10.5)
Ward type [n, (%)]
Cardiology 4 (57.1) 4 (57.1) 2 (40.0) 10 (52.6)
Internal Medicine 2 (28.6) 2 (28.6) 2 (40.0) 6 (31.6)
Pulmonology 1 (14.3) 1 (20.0) 2 (10.5)
Neurology 1 (14.3) 1 (5.3)
Fig. 1 Fishbone diagram of patient-reported barriers to medication use during the transition from hospital to home
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lead to problems in understanding the information
given:
“But I had a brain hemorrhage and I must think
thoroughly about something before I can really take it
in. I really need that one to one communication and
people taking time for me. Even then, it is still
doubtful if I really take it in, you know.”(Female, 54
years-old, internal medicine)
Also, according to several patients, potential treatment-
related side effects were rarely discussed with them during
hospitalization:
“Something I think can be improved, and which really
did not happen in my case, but may not be the same
for everyone, is that they indicate in advance what
may be possible side effects of the medication.”
(Male, 73 years old, cardiology)
In contrast, for some patients knowing about all the
potential side effects in advance causes harm rather than
relief:
“You may get dizzy if you know, and if you don’t, you
won’t.” (Female, 80 years, pulmonology)
Emotional support from healthcare providers
During the focus groups, some patients mentioned that
the start of a new medication therapy during their hospital
stay can feel overwhelming. They feel that healthcare pro-
viders do not always notice the impact of medication
changes on a patient’s mental well-being and sometimes
miss their emotional support to cope with these changes:
“In any event, it is quite a shock if you have never used
medication and suddenly have to take so many all at
once. Then you think, well, this may save me for the
time being, but soon I will die from some other cause
anyway. And of course they don’t pay attention to
that.” (Male, 73 years old, cardiology)
Post-discharge follow-up
Some patients questioned whether healthcare providers
assess if patients are capable of using and managing
medication independently post-discharge, as patients are
expected to self-manage their medication regimen post-
discharge. Patients considered especially vulnerable pa-
tients, such as the elderly, who are often prescribed
many medications, are at a higher risk of improper
post-discharge medication use when they do not receive
post-discharge guidance.
“… With regard to the medication, after having been
discharged, I also think that they (the healthcare
providers) should assess very well whether this lady is
able to manage everything on her own. … because … I
have also stood up in the morning and thought,
alright, that is a bag full of medication. Then I think,
okay, well, I will arrange everything neatly, in a
relaxed way, but I’m fifty-four.”(Female, 54 years old,
cardiology)
Theme ΙΙ – insufficient information transfer
Communication between healthcare providers
Many patients mentioned that communication between
healthcare providers on changes in pharmacotherapy
often seems to be lacking. Therefore, patients fear mis-
takes in their medication; one patient even mentioned
that this results in distrust of his healthcare providers:
“My Metformin was reduced from two to one. Then I
visited my GP and had to explain to him that it had
been reduced to one. A week later I visited the nurse
and I had to recount the whole story all over again.
Then, I came to the hospital and the doctor says ‘so
you are taking two tablets of Metformin’. ‘No I have
been on one tablet for over two months now’. Then I
think to myself: Come on guys, if you are making
mistakes with that, I wonder what mistakes you are
making with my medication. So I don’t have much
confidence in this business here.”(Male, 56 years old,
cardiology)
Consequently, some patients feel responsible for an
adequate information transfer between healthcare pro-
viders and introduce solutions themselves:
“I did that when I was given a lot of medications, four
other medications; I made a complete list for the
pharmacist, sending a CC to my GP, because it turns
out that my GP does not always, or rather, hardly ever,
receives a list from the hospital of the medications that I
take.”(Male, 80 years old, cardiology)
Medication overview
At hospital discharge, patients often receive a medica-
tion overview, listing their medication. However, accord-
ing to many patients, this overview is often incomplete
when patients do not pay attention:
“The various medications you get from the hospital are
listed, but the rest is what you indicate yourself, so if
you forget something, it won’t be on the medication
overview either.” (Male, 62 years old, pulmonology)
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Theme ΙΙΙ – problems in organization of healthcare
Organization of the discharge process
Many patients find it frustrating when they have to wait
for a long time to get their medication supply, especially
when the discharge time is planned beforehand. Some
patients mentioned this results in wanting to leave the
hospital without getting any medication.
“At eleven o’clock I could go home and I was so happy,
but then I had to wait until four o’clock for my
medication. I became cranky about that; I said to my
husband, I will go home without my medication, I
don’t care what they think.”(Female, 75 years old,
internal medicine)
Furthermore, some patients experience problems in
receiving sufficient medication when they are discharged
just before the weekend. The supply of medication dis-
pensed at discharge is not always enough to last until
refill prescriptions are available from their usual source
(e.g. community pharmacy).
Substitution of medication
The substitution of medication (e.g. switch from brands
to generics), during the transition from hospital to home
confuses and sometimes frightens patients. Substituted
medication often looks different from the medication
they are used to taking and therefore many patients fear
using the substitute:
“I did indeed get medication that looked very different;
then, it is really scary to take them. The other (usual)
ones you just swallow.” (Female, 75 years old, internal
medicine)
Facilitators to overcome identified barriers with medication
use during the transition from hospital to home
Many facilitators were suggested by patients to over-
come identified (sub) themes of barriers and are pre-
sented in Fig. 2. Some facilitators were mentioned that
were not directed at a specific barrier but were generally
perceived as helpful, including the improvement of phar-
macy logistics. For instance, by introducing a locker
service with 24/7 accessibility, which allows patients to
collect their medication anytime of the day and skip
queues, or to assign one dedicated pharmacy assistant in
the pharmacy who is responsible for preparing all the
discharge prescriptions.
Overall, patients agreed that facilitators should at least
target vulnerable patients and should anticipate their
preferences to result in more personalized care.
Also, patients reported that information on medication
use, management or side effects, should always be provided
both verbally and written, as patients are often distracted
during hospitalization and therefore might not comprehend
given instructions right away:
“That is why it is so important to give the oral
explanation at the time of discharge, but it also
depends on what kind of person it concerns, what his
state of mind and condition is. There are people who
are actually not well enough to go home, who
shouldn’t be discharged, but who are sent home
anyway because there is no medical reason to keep
them hospitalized. They may have all kinds of worries
in their heads. Therefore, it would be good to get a
written explanation in addition to the oral one.”
(Male, 62 years old, pulmonology)
Also, according to patients, communication problems
among healthcare providers regarding changes in pharma-
cotherapy could be targeted when healthcare providers
from both primary and secondary care organize regular
meetings together and discuss patient changes in medica-
tion regimens and any encountered MRPs. Patients sug-
gested the use of one national health record system by
healthcare providers.
From all of the suggested facilitators, in total, 2 main
themes were identified: personal medication-counsellor
in the care continuum and post-discharge follow-up care
(Fig. 2) which are further described below. Both types of
facilitators could overcome more than one (sub) theme
of identified barriers.
Personal medication-counsellor in the care continuum
Predominantly, all patients were in favor of introducing
a personal medication-counsellor for patient-centered
medication care in the care continuum. The counsellor
could be assigned to every patient who is in need of
extra care and could closely monitor patients. Patients
agreed that this person could assess a patient’s capability
to use and manage medication at home, and discuss
potential problems and solutions:
“If he has a conversation with you within a reasonable
period of time, he will see what the weak points are,
and then he can discuss with you there and then how
to correct these, or say: we will solve it in that way.”
(Male, 56 years old, cardiology)
Patients discussed that this counsellor should focus on
their personal issues, preferences and needs and should
be able to empathize with the patient:
“The point is that he is a human being. It is about
human beings, after all. It is a human being who is
listening to what we have to say, and who actually
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takes the trouble of finding out hey, this is this
gentleman’s problem or that is his or her problem, we’ll
try and figure out what is going on here.” (Male, 56
years old, cardiology)
Overall, patients expressed that the counsellor could
act as a point of contact between the patient and the
healthcare providers in the care continuum:
“You are given so much information; you are told this
by one and that by another, but part of it just does not
fit. There should be one point of contact.” (Male, 78
years old, cardiology)
Patients agreed that the patient-counsellor should be a
professional who is familiar with medication therapies
and is able to communicate with patients and other
healthcare providers. Some believed that general practi-
tioners, nurses or pharmacists were the best profes-
sionals to fulfil this role, because they are more closely
related to the patient compared to others. However, pa-
tients also acknowledged that this would most likely be
an expensive service and therefore probably not feasible.
Post-discharge follow-up care
Follow-up care after hospital discharge was also seen as
an important facilitator to overcome the mentioned bar-
riers during the transition from hospital to home.
For instance, many patients agreed that a simple
phone call post-discharge by a healthcare provider is
always appreciated, as it makes them feel cared for and
safer with medication use. Mostly, patients mentioned
that a home visit post-discharge, which they received
during their participation in the pharmacy-led transi-
tional care program, [26] is a facilitator, especially when
changes are conducted in the pharmacotherapy. They
felt that this visit clarified medication use and manage-
ment, and led to practical advice adjusted to their own
needs:
“Just to monitor the home situation, see how all
the various medication is used and taken, how
they are dealt with and how they are stored. I
think that is also, it may be very helpful if that is
thoroughly examined.” (Male, 73 years old,
cardiology)
Moreover, patients perceived a home visit as additional
support for their therapy and found this additional at-
tention pleasant:
“It is quite a reassurance that this is done; it means
the continuation of hospital care at home is well-
organized … it is given attention, which is really great.”
(Male, 79 years old, pulmonology)
Patients emphasized that this could also lower the
threshold for patients to ask questions regarding medi-
cation. Some patients, however, felt that they were being
monitored during the home visit in the way that they
were using or managing their medication: “The idea that
the pharmacist really came to check if you were not mes-
sing up the medication, and if I could figure it all out.
He was not only there as, say, a support, he was really
looking whether I took my medication each time.”(Male,
75 years old, cardiology).
Fig. 2 Fishbone diagram of patient-reported facilitators to overcome identified barriers during the transition from hospital to home
Daliri et al. BMC Health Services Research          (2019) 19:204 Page 7 of 10
Discussion
This qualitative study provides insight into perspectives
of patients on barriers and facilitators of medication use,
during the transition from hospital to home. Barriers in-
cluded a lack of personalized care, insufficient information
transfer between healthcare providers, and problems in
the organization of healthcare. Many practical solutions
were suggested by patients to overcome the identified
(sub) themes of barriers, of which 2 main themes of facili-
tators were identified: a personal medication-counsellor in
the care continuum and post-discharge follow-up care by
qualified healthcare providers.
Overall, the findings of the study indicate that patients
do not feel that care is personalized to their preferences,
needs or functional status. As the study results show,
many patients have difficulty using their medication
adequately due to cognitive impairment, or because they
encounter difficulties with medication adherence as they
receive insufficient medication management tools or (so-
cial) support. This can ultimately result in MRPs post-dis-
charge, as shown by previous studies [5, 6, 32]. The
introduction of personalized care could be promising to
facilitate safe medication use in the care continuum, as it
has already shown improvements in people’s physical and
psychological health status, and patients’ capability to
self-manage their condition when compared to usual care
[33–35]. However, according to Hesselink et al. [18], pro-
viding personalized care during hospitalization is often
difficult for healthcare providers because of the hurried
discharge processes, which are often not well prepared,
and incorrect estimations of patients’ capabilities and in-
formational needs. To that end, patients in this study sug-
gested that an assessment should be made by healthcare
providers during hospitalization, to evaluate which pa-
tients are in need of extra care. Those patients should be
appointed a personal medication-counsellor, who provides
care tailored to their needs and helps to overcome barriers
during transitions in care. It does not matter to patients
which professional fulfils this role, as long as this person is
closely related to the patient and could act as a point of
contact between his or her involved healthcare providers
in the care continuum. Introducing a qualified nurse as a
‘transition coach’ during hospital discharge has been
found to reduce hospital readmission rates in chronically
ill patients [36]. Although promising, this study did not
investigate the effect on the occurrence of post-discharge
MRPs, such as adverse drug events, which are known to
affect patients’ health and quality of life [3, 5, 13, 37].
Another effective intervention is the provision of post-dis-
charge follow-up care, such as home visits [38–40]. Nearly
all patients in this study widely appreciated the home
visits, as they received support on medication use and
practical advice adjusted to their own needs (e.g.
dose-dispensing systems for patients who regularly forget
to take their medication). On the other hand, patients ac-
knowledged that this service would most likely be expen-
sive and moreover, not necessarily needed for everyone or
after every hospitalization. Thus, finding the right balance
between the provision of care by healthcare providers and
inquiring patients’ needs in care transitions is essential.
In addition to a lack of personalized care, patients also
experienced inadequate transfer of changes in pharma-
cotherapy, which is a known problem and has been
linked to increased MRPs and unplanned readmissions
several times [5, 6, 9, 15, 16]. These communication
breakdowns had an impact on patients’ trust in their
healthcare provider as they feared errors in their medica-
tion overviews due to incorrect handovers. Proposed
facilitators to address this barrier included enhancing re-
lationships between primary and secondary healthcare
providers, by organizing frequent gatherings to discuss
patients’ potential MRPs. Also, some patients mentioned
the engagement of patients as active participants, which
results in safer handover communication and lower
re-hospitalization rates [36, 39].
Finally, the study findings elucidate obstacles patients
perceive with the organization of processes in the hospital,
specifically, the substitution of branded and generic medi-
cation. In the Netherlands, formulary agreements, specify-
ing the type and brand of medication approved for
prescribing, often differs between primary and secondary
healthcare settings. Hospital (outpatient) pharmacies often
supply the branded version (due to discounts for branded
medication), whereas community pharmacies generally dis-
pense generic medications. The brand and generic drug,
however, may appear completely different to the patient
due to different packages and pill appearance, which can
result in decreased adherence to and persistence of medica-
tion use [40]. To address this barrier and avoid confusion
with medication use, patients find it important to be in-
formed about their changed medication, both verbally and
by written communication [9].
Altogether, perceived barriers by patients could be un-
known or invisible to healthcare providers as patients’
assessment of quality in care is not always aligned with
that of healthcare providers [41]. Therefore, to reduce
post-discharge MRPs, future research into perspectives
of healthcare providers on barriers and facilitators dur-
ing the transition from hospital to home is needed as
well.
Strengths and limitations
The primary strength of this study is the identification
of barriers and facilitators specifically for medication use
from a patient perspective, which could help with the
development of effective interventions to reduce MRPs.
Furthermore, identified barriers were schematically visu-
alized using a fishbone diagram. This analytical tool has
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already been used in several studies to generate solutions
to or identify causes of a quality of care problem [42, 43].
However, some limitations should be acknowledged.
First, patients were selected from the intervention group
of a larger study which can influence the study results,
as patients already knew some facilitators throughout
the received interventions. This is especially notable for
patients perceiving a home visit as a facilitator. It is pos-
sible that other (sub) themes would have been identified
if focus groups had been performed with patients who
did not receive any intervention. However, patients have
difficulties to reflect on their needs if they are not
queued about the possibilities [10] and therefore, we be-
lieve that the selection of the intervention group pro-
vided a better insight into barriers and facilitators, as
patients reflected on previous experiences with transi-
tions in care. Second, because a relatively small group of
patients from the intervention group participated, it
might be possible that selection bias occurred. Nonethe-
less, the demographic characteristics were essentially
similar in both groups, indicating qualitative clarity. Fur-
thermore, no new themes emerged in the third focus
group and therefore, data can be considered to be com-
prehensive. Also, according to literature, a sample size of
2 to 3 focus groups will likely capture at least 80% of
themes on a topic—including those most broadly
shared—in a study with a relatively homogeneous popu-
lation using a semistructured guide [44] which was the
case for our focus groups. In addition, two comparable
qualitative research studies on this topic, interviewed
13–19 patients and also reported considerable agree-
ment between participants [24, 45].
Finally, some barriers are related to the local Dutch
organization of care and could therefore differ between
settings and countries. However, the identified themes,
especially the barriers, are similar to what other studies
have found [46] e.g. communication barriers, medication
dispensing problems, which in our opinion indicates that
these study results are not only relevant to locally situ-
ated patients or healthcare providers. Still, future re-
search should be conducted to replicate our findings.
Conclusions
During transitions from hospital to home patients experi-
ence individual-, healthcare provider- and organization
level barriers that can lead to MRPs post-discharge. To re-
duce these problems, the care provided should be more
personalized, taking patient’s values, preferences and
needs into account. Future research should focus on
personal-medication counselors in the care continuum
and post-discharge follow-up care as it may overcome
communication, emotional, information and organization
barriers with medication use.
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